We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+26.16%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$11.4B
AUM Growth
+$1.76B
Cap. Flow
-$330M
Cap. Flow %
-2.89%
Top 10 Hldgs %
18.38%
Holding
1,151
New
138
Increased
341
Reduced
503
Closed
146

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$32.1M
2
INTC icon
Intel
INTC
+$28.7M
3
GILD icon
Gilead Sciences
GILD
+$27.7M
4
APA icon
APA Corp
APA
+$27.5M
5
COST icon
Costco
COST
+$25.1M

Sector Composition

Rank Sector Weight
1 Technology 26.64%
2 Healthcare 14.08%
3 Consumer Discretionary 13.88%
4 Financials 13.05%
5 Industrials 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QTNT
951
DELISTED
Quotient Limited Ordinary Shares
QTNT
$237K ﹤0.01%
1,137
-109
-9% -$25.4K
PRTK
952
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$232K ﹤0.01%
+36,990
New +$218K
ALK icon
953
Alaska Air
ALK
$5.11B
$229K ﹤0.01%
4,397
-7,143
-62% -$321K
BMY icon
954
Bristol-Myers Squibb
BMY
$129B
$226K ﹤0.01%
+3,643
New +$224K
PROS
955
DELISTED
ProSight Global, Inc.
PROS
$226K ﹤0.01%
17,577
-7,363
-30% -$91.1K
BHVN
956
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$223K ﹤0.01%
2,601
-80,964
-97% -$6.86M
BOC icon
957
Boston Omaha
BOC
$436M
$219K ﹤0.01%
+7,914
New +$161K
NATR icon
958
Nature's Sunshine
NATR
$362M
$219K ﹤0.01%
14,643
DSGR icon
959
Distribution Solutions Group
DSGR
$1.6B
$218K ﹤0.01%
+8,558
New +$204K
PMBC
960
DELISTED
Pacific Mercantile Bancorp
PMBC
$215K ﹤0.01%
+41,900
New +$185K
SRCE icon
961
1st Source
SRCE
$2.17B
$208K ﹤0.01%
+5,165
New +$189K
BOCH
962
DELISTED
Bank of Commerce Holdings (CA)
BOCH
$206K ﹤0.01%
20,787
ARAV
963
DELISTED
Aravive, Inc. Common Stock
ARAV
$205K ﹤0.01%
36,414
-921
-2% -$5.05K
MRTX
964
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$201K ﹤0.01%
+914
New +$198K
MOV icon
965
Movado Group
MOV
$840M
$200K ﹤0.01%
12,061
+145
+1% +$2.07K
EYPT icon
966
EyePoint Inc
EYPT
$999M
$186K ﹤0.01%
+28,285
New +$132K
FULC icon
967
Fulcrum Therapeutics
FULC
$241M
$184K ﹤0.01%
15,692
-647
-4% -$7.32K
VATE icon
968
INNOVATE Corp
VATE
$106M
$184K ﹤0.01%
5,659
+2,820
+99% +$78.4K
WSR
969
DELISTED
Whitestone REIT
WSR
$174K ﹤0.01%
21,892
-7,094
-24% -$51K
BCEL
970
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$168K ﹤0.01%
+10,416
New +$156K
GHM icon
971
Graham Corp
GHM
$1.03B
$167K ﹤0.01%
11,017
-3,905
-26% -$57.4K
CLPR
972
Clipper Realty
CLPR
$46.4M
$165K ﹤0.01%
+23,411
New +$145K
PFHD
973
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
$159K ﹤0.01%
10,291
-377
-4% -$5.5K
LOGC
974
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$154K ﹤0.01%
20,245
-42,976
-68% -$288K
BCBP icon
975
BCB Bancorp
BCBP
$179M
$146K ﹤0.01%
13,223
+1,713
+15% +$17K

Similar funds

Jacobs Levy Equity Management's Q4 2020 Portfolio in Review

As of Q4 2020, Jacobs Levy Equity Management held 1,151 positions worth $11.4B, up 18% from $9.65B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Jacobs Levy Equity Management's Q4 2020 filing shows 138 new, 341 increased, 503 reduced and 146 closed positions. Its largest new stake was DexCom: 229,736 shares worth $21.2M. The largest sale was Optimum Communications Inc, an estimated $41M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q4 2020 buy was DexCom: 229,736 shares worth $21.2M.
  • Jacobs Levy Equity Management added most to Amazon in Q4 2020, an estimated $32.1M increase.
  • Jacobs Levy Equity Management's biggest Q4 2020 reduction was Qualcomm, cutting an estimated $33.6M.
  • Jacobs Levy Equity Management fully exited Optimum Communications Inc in Q4 2020, selling an estimated $41M.
  • Jacobs Levy Equity Management's ten largest holdings make up 18% of its $11.4B portfolio in Q4 2020.
  • Jacobs Levy Equity Management opened 138 new positions and closed 146 in Q4 2020.
  • Jacobs Levy Equity Management's portfolio value rose 18% quarter-over-quarter to $11.4B.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2020, filed 16 Feb 2021.